AMA, DiMe launch AI framework for physicians amid rapid tech progress
The American Medical Association (AMA) and the Digital Medicine Society (DiMe) have released a new framework and roadmap for physicians navigating the rapidly evolving landscape of AI in healthcare. This initiative aims to define physicians' enduring responsibilities, emphasizing patient trust, clinical judgment, and safe implementation of technology, amid discussions about AI's potential to transform or even surpass human medical expertise. The framework outlines five key responsibilities for physicians and suggests collaborative actions for various stakeholders, including patients, developers, and policymakers.
Securities Fraud Investigation Into GE HealthCare
Glancy Prongay Wolke & Rotter LLP has launched an investigation into GE HealthCare Technologies Inc. (GEHC) for possible federal securities law violations. This follows a 13.2% stock price drop after GE HealthCare reported lower-than-expected Q1 2026 earnings and cut its full-year guidance due to a recall and supplier issues, as well as the subsequent announcement of its CFO stepping down. The law firm is urging investors who lost money to contact them regarding potential claims.
Securities Fraud Investigation Into GE HealthCare
Glancy Prongay Wolke & Rotter LLP is continuing its securities fraud investigation into GE HealthCare Technologies Inc. (GEHC). The investigation follows a 13.2% stock price drop after GE HealthCare reported lower-than-expected Q1 2026 earnings and cut its full-year guidance, citing issues with a PDx supplier. The company also announced that its Chief Financial Officer, Jay Saccaro, would be stepping down.
Global Cardiovascular Devices Market to Reach $101.6 Billion by 2030, Says BCC Research Analyst
The global cardiovascular devices market is projected to grow from $72.4 billion in 2025 to $101.6 billion by 2030, driven by an aging population, increased disease prevalence, and advancements in minimally invasive procedures and remote monitoring. Key trends include the adoption of leadless pacemakers, pulsed field ablation, and AI-enabled cardiac monitoring solutions. Major players like Abbott, Boston Scientific, and Medtronic dominate the market, while innovators introduce next-generation implantable and bioresorbable devices.
Securities Fraud Investigation Into GE HealthCare
The Law Offices of Frank R. Cruz is continuing its investigation into GE HealthCare Technologies Inc. (GEHC) for potential violations of federal securities laws. This follows a significant 13.2% stock price drop on April 29, 2026, after the company reported lower-than-expected first-quarter earnings and cut its full-year EPS guidance due to a recall associated with a PDx supplier and declines in PCS. The investigation also notes the subsequent announcement of CFO Jay Saccaro's resignation on July 23, 2026.
GE HealthCare Technologies Inc. stock rises Wednesday, outperforms market
GE HealthCare Technologies Inc. (GEHC) stock rose 2.74% on Wednesday, closing at $74.62. This performance outpaced the broader market, with both the S&P 500 Index and the Dow Jones Industrial Average also seeing gains. This marks the second consecutive day of increases for GE HealthCare Technologies Inc. stock.
GE HealthCare appoints William Grogan as Chief Financial Officer
GE HealthCare has announced the appointment of William (Bill) Grogan as its new Chief Financial Officer, effective September 14, 2026. Grogan previously served as EVP and CFO at Xylem Inc., and prior to that, spent over a decade at IDEX Corporation. He is expected to lead GE HealthCare's financial strategy, focusing on growth, operational efficiency, and long-term value creation.
GE HealthCare names new CFO
GE HealthCare has appointed William Grogan as its new CFO, filling the vacancy left by Jay Saccaro. Grogan, formerly CFO at Xylem, is set to join GE HealthCare on September 14, 2026. Analysts from Stifel and RBC Capital Markets have welcomed the appointment, citing Grogan's strong track record in meeting earnings expectations, expanding margins, and simplifying operating systems, despite his lack of specific medtech experience.
How providers can weather Medicaid cuts when many won't
Federal Medicaid reforms, including work requirements and tightened eligibility, are expected to significantly impact healthcare providers, with rural and Medicaid-dependent hospitals facing the greatest financial risks and potential closures. While some providers are innovating through technology and value-based care models to mitigate revenue losses, a substantial increase in uncompensated care costs and access barriers for vulnerable populations are anticipated. Patient education will be crucial to help individuals navigate new Medicaid requirements and maintain coverage.
GE HealthCare appoints new CFO
GE HealthCare has appointed William (Bill) Grogan as its new chief financial officer, effective September 14, 2026. Grogan brings extensive financial leadership experience from Xylem Inc. and IDEX Corporation, where he significantly contributed to growth and financial performance. His appointment follows other recent leadership changes at GE HealthCare, as the company aims to simplify operations and accelerate its precision care strategy.
GE HealthCare Hires Bill Grogan as Finance Chief
GE HealthCare has appointed William (Bill) Grogan as its new chief financial officer, effective September 14, 2026. Grogan previously served as executive VP and CFO at Xylem Inc., and held finance leadership roles at IDEX Corp., Walgreens, Crane Co., and Sears Holdings Corp. He succeeds Jay Saccaro, who announced his departure last month.
Is GE HealthCare’s New AI Laptop Ultrasound Push Reshaping Its Imaging Strategy And Moat (GEHC)?
GE HealthCare has launched new AI-enabled laptop ultrasound systems, LOGIQ e family, to enhance its portable imaging capabilities and digital integration. This move reinforces its strategy in imaging and diagnostics, aiming to expand its installed base and integrate AI and cloud technology, as highlighted by a recent partnership with Catholic Health. Despite potential growth from these initiatives, investors are advised to consider risks such as tariffs, China policy changes, and competition.
HOTCHKIS & WILEY Trims APA Corp (APA) Stake -- Shares Trade 62% Above GF Value
Hotchkis & Wiley recently reduced its stake in APA Corp (APA) by selling 319,811 shares at $32.57 each, though still retaining a substantial 8.97% ownership. This reduction comes as APA's stock trades 62% above its GF Value, indicating significant overvaluation despite strong profitability. The firm's move reflects a disciplined value investing approach, acknowledging the company's strengths while adjusting to current market conditions.
GE HealthCare Technologies (GEHC) HR chief reports tax share withholding
GE HealthCare Technologies Inc. (GEHC) Chief People Officer Adam Y. Holton had 1,360 shares of common stock withheld on August 15, 2026, to cover tax obligations related to the vesting of restricted stock units. Following this transaction, Holton directly holds 20,865 GEHC shares. The shares were withheld at a price of $73.69 each, totaling approximately $100,000.
Form 8K GE HealthCare Technologies Inc For: 18 August By Investing.com
This article announces that GE HealthCare Technologies Inc. filed a Form 8K on August 18th. The brief piece from Investing.com provides no further details beyond this regulatory filing announcement. It includes typical financial market data and related news snippets.
KT, SNUH partner on AI-native hospital platform
KT Corp. and Seoul National University Hospital (SNUH) have formed a partnership to develop an AI-powered healthcare platform. This collaboration aims to integrate SNUH's clinical expertise with KT's AI, cloud, and data technologies to create a standard AI model for South Korea's public healthcare system. The initiative will involve developing AI-based clinical decision support systems and solutions for hospital operational efficiency, with plans to expand these models to other medical institutions.
Whirlpool Showcases Apprenticeship Programs During Visit From Acting U.S. Labor Secretary Keith Sonderling
Whirlpool Corp. highlighted its nearly 70-year-old apprenticeship program during a visit from Acting U.S. Secretary of Labor Keith Sonderling to its Clyde facility, the world's largest washing machine factory. The visit showcased Whirlpool's $300 million investment in its Ohio operations and emphasized its commitment to U.S. manufacturing and workforce development through skilled trades programs. Sonderling praised Whirlpool as a leader in both American manufacturing and workforce development, aligning with the Department of Labor's focus on industry-driven innovation.
How a clinical-reasoning framework can help improve smaller AI models' performance
Researchers from Carnegie Mellon University, Weill Cornell Medicine, and Indiana University School of Medicine have developed a framework called Differential Reasoning Learning (DRL) to improve the performance of smaller, more affordable AI models in clinical decision-making. This framework compares smaller AI models against larger ones and human physicians' reasoning to identify and correct errors like omissions and hallucinations. The goal is to make high-quality AI more accessible and cost-effective for small and rural hospitals, especially for critical tasks like patient discharge decisions.
Form 8K GE HealthCare Technologies Inc For: 18 August By Investing.com
This article announces the filing of a Form 8K by GE HealthCare Technologies Inc. on August 18. It is a brief report primarily serving as a notification of this corporate action. The content is very minimal, focusing solely on the filing event itself.
GE HealthCare Appoints William Grogan as New CFO
GE HealthCare has appointed William K. Grogan as its new Chief Financial Officer, effective September 14, 2026. Grogan, bringing extensive financial leadership experience from Xylem Inc. and IDEX Corporation, will succeed interim CFO George A. Newcomb. His compensation package includes a significant base salary, bonus, and multi-year equity incentives, aiming to align his financial incentives with the company's long-term shareholder value and governance standards.
Form 8K GE HealthCare Technologies Inc For: 18 August By Investing.com
GE HealthCare Technologies Inc. (GEHC) filed a Form 8K on August 18, 2026. The article from Investing.com simply notes this filing and its association with the company. The company's stock showed a 1.11% increase at the time of publication.
Form 8K GE HealthCare Technologies Inc For: 18 August By Investing.com
This article announces the filing of a Form 8K by GE HealthCare Technologies Inc. on August 18. It is a brief notification from Investing.com, typical of regulatory filing alerts, and includes financial market data and other unrelated news snippets.
New GE HealthCare (GEHC) CFO hired with multimillion pay deal
GE HealthCare has appointed William (Bill) Grogan as its new Chief Financial Officer, effective September 14, 2026. Grogan, formerly CFO of Xylem Inc., will receive a compensation package including a $900,000 base salary, a target annual bonus of 100% of his base salary, and significant long-term incentive awards totaling over $7 million, including a cash sign-on payment and restricted stock units. This strategic hire aims to support GE HealthCare's precision care strategy and drive long-term value creation.
GE HealthCare Appoints William Grogan as CFO Sept. 14 | GEHC Stock News
GE HealthCare (Nasdaq: GEHC) has announced the appointment of William (Bill) Grogan as its new Chief Financial Officer, effective September 14, 2026. Grogan joins from Xylem Inc., where he served as CFO and was instrumental in integrating a $7.5 billion acquisition, driving significant margin expansion, and optimizing capital deployment. His previous experience also includes over a decade at IDEX Corporation, where he repositioned its portfolio towards higher-growth markets and contributed to a doubling of the company's market capitalization.
Johnson & Johnson Publishes New Future of Digital Surgery Report to Help Define the Emerging Field of Surgical Intelligence
Johnson & Johnson has published a new report, "Surgery’s Next Inflection Point: The Rise of Surgical Intelligence," highlighting the transformative potential of connected data, AI, and intelligent systems in surgery. The report introduces a common framework for surgical intelligence, defining it as clinical knowledge derived from multimodal data across the perioperative pathway to generate actionable insights. It emphasizes that scaling surgical intelligence requires not just technological advancement but also trusted governance, interoperability, and collaboration across the healthcare ecosystem.
Prospect Hill Management LLC Takes Position in Thermo Fisher Scientific Inc. $TMO
Prospect Hill Management LLC has acquired a new position of 3,000 shares in Thermo Fisher Scientific Inc. (NYSE:TMO) during the second quarter, valued at approximately $1.5 million. Institutional investors and hedge funds collectively own 89.23% of the company, with analysts maintaining a "Moderate Buy" rating and an average price target of $619.41. The company recently exceeded quarterly expectations with $6.03 EPS and $11.99 billion in revenue, also declaring a quarterly dividend of $0.47 per share.
AI in healthcare: Are you tracking the right competitors?
This article discusses how patent intelligence can reveal unexpected competitors in the rapidly evolving field of AI in healthcare. It highlights that medical technology companies are leading in AI-related patent filings, and relevant AI capabilities are emerging from diverse industries such as computing and digital platforms, not just traditional life sciences. The author suggests that IP teams should track technologies across industry boundaries to identify potential partners, acquisition targets, or competitive threats early on.
NewEdge Advisors LLC Has $1.23 Million Stock Holdings in TTM Technologies, Inc. $TTMI
NewEdge Advisors LLC significantly increased its stake in TTM Technologies, Inc. by 385.0% in the first quarter, bringing its holdings to $1.23 million. Other institutional investors like Invesco Ltd. and Whale Rock Capital Management LLC also increased their positions. Analysts have set an average "Buy" rating and a target price of $214.25 for TTM Technologies, which recently reported strong quarterly earnings exceeding expectations.
Flputnam Investment Management Co. Makes New Investment in DexCom, Inc. $DXCM
Flputnam Investment Management Co. has reported a new investment in DexCom, Inc. (NASDAQ:DXCM), purchasing 15,705 shares valued at approximately $1.058 million during the second quarter. Other institutional investors also adjusted their holdings, and the article details recent insider stock sales and DexCom's financial performance. Analyst ratings for DexCom are predominantly "Buy" or "Strong Buy," with an average target price of $88.71.
Flputnam Investment Management Co. Takes $1.52 Million Position in Becton, Dickinson and Company $BDX
Flputnam Investment Management Co. recently acquired a $1.52 million stake in Becton, Dickinson and Company (BDX) during the second quarter, purchasing 10,080 shares. Institutional investors collectively own 86.97% of the company. Becton, Dickinson and Company exceeded analyst expectations with its recent earnings, reporting $4.98 billion in revenue and $3.23 EPS, while also maintaining its fiscal 2026 EPS guidance.
3,117 Shares in HCA Healthcare, Inc. $HCA Acquired by Global Retirement Partners LLC
Global Retirement Partners LLC acquired 3,117 shares of HCA Healthcare, Inc. (NYSE:HCA) valued at approximately $1.2 million during the second quarter. This move is part of a broader trend where institutional investors now own 62.73% of the company's stock, with several other major funds also increasing their positions. Despite some recent price target reductions, analysts maintain a "Moderate Buy" consensus rating for HCA Healthcare, with an average price target of $465.59.
GE HealthCare Technologies Inc. stock falls Monday, underperforms market
GE HealthCare Technologies Inc. (GEHC) saw its stock fall by 1.79% to $72.37 on Monday, underperforming the broader market. This decline occurred during a generally negative trading session where the S&P 500 Index and Dow Jones Industrial Average also experienced losses. This marks the second consecutive day of losses for GE HealthCare Technologies Inc.
J&J’s Monarch robot wins FDA nod for AI features
Johnson & Johnson's Monarch bronchoscopy robot has received FDA clearance for a software update that integrates artificial intelligence features. These enhancements aim to improve pre-procedure planning, navigation, and targeting during lung cancer diagnosis procedures. The Monarch system, which competes with Intuitive's Ion and Noah Medical's Galaxy, now offers more accurate nodule boundary generation and improved visual orientation for physicians.
Nelson Peltz Is Now Betting on Both Sides of GE's Breakup
Nelson Peltz's Trian Fund Management has significantly increased its stake in GE HealthCare Technologies (GEHC) while maintaining its position in GE Aerospace (GE). This move indicates Peltz's continued belief in the value created by General Electric's multi-year breakup, now holding meaningful investments in two of the successor companies. The long-term activist investor appears to be betting on the independent success of both industrial entities.
Radiopharm schedules FDA meeting for brain imaging agent RAD101 By Investing.com
Radiopharm Theranostics has scheduled an End-of-Phase 2 meeting with the FDA for October 1, 2026, to discuss the Phase 3 trial design for its brain imaging agent, RAD101. RAD101, which has FDA Fast Track Designation, is developed to distinguish recurrent brain metastases from treatment effects after radiotherapy. The company aims to be Phase 3-ready by year-end 2026 and has partnered with Siemens Healthineers for manufacturing and distribution.
Diamond Hill Capital Management LLC Investment Advisor Buys Shares of 44,202 Teledyne Technologies Incorporated $TDY
Diamond Hill Capital Management LLC has acquired 44,202 shares of Teledyne Technologies (NYSE: TDY) for approximately $29.5 million, representing a 0.10% stake in the company. This investment comes as Teledyne reported strong quarterly earnings, exceeding estimates with $6.28 EPS and a 9.8% revenue increase, and provided optimistic fiscal 2026 guidance. Analysts maintain a "Moderate Buy" rating, with an average price target of $721.67, suggesting potential upside from its current trading price of around $680.
OneDigital Investment Advisors LLC Makes New $11.53 Million Investment in DexCom, Inc. $DXCM
OneDigital Investment Advisors LLC has made a new $11.53 million investment in DexCom, Inc. (NASDAQ:DXCM), purchasing 171,242 shares. This comes as institutional investors collectively own 97.75% of the company, and Wall Street analysts maintain a "Moderate Buy" rating with an average target price of $88.71. Despite positive quarterly earnings exceeding expectations, company insiders have sold nearly 100,000 shares in the past 90 days.
GSA Capital Partners LLP Makes New Investment in PepGen, Inc. $PEPG
GSA Capital Partners LLP has initiated a new investment in PepGen, Inc. (NASDAQ:PEPG), acquiring 852,852 shares valued at approximately $1.535 million, representing a 1.23% stake. This investment comes as institutional ownership in PepGen collectively stands at 58.01%. The company recently reported better-than-expected quarterly EPS of -$0.26, and analysts maintain a "Moderate Buy" rating with an average price target of $11.50.
CGN Advisors LLC Increases Holdings in Amazon.com, Inc. $AMZN
CGN Advisors LLC significantly increased its stake in Amazon.com, Inc. by 10.7% in the second quarter, bringing its total holdings to 42,468 shares valued at approximately $10.1 million. This move is part of a broader trend of institutional investors, who collectively own 72.2% of Amazon, growing their positions. Despite strong Q2 earnings, rising AWS demand, and an optimistic "Moderate Buy" consensus rating from Wall Street, the article notes ongoing debates regarding Amazon's valuation and risks associated with AI investment and retail spending concerns.
Radiopharm Theranostics (ASX:RAD) Sets October FDA Meeting as RAD101 Moves Toward Phase 3
Radiopharm Theranostics has scheduled an End-of-Phase 2 meeting with the U.S. FDA for October 1, 2026, to discuss the Phase 3 trial design for its imaging agent, RAD101. This comes after RAD101 achieved 93% concordance between MRI and PET imaging in its Phase 2b study, moving the company closer to a registrational trial. Siemens Healthineers will support the manufacturing and distribution of RAD101 doses for the planned U.S. Phase 3 study, which Radiopharm aims to advance by the end of 2026.
Sandro Wealth Management LLC Buys Shares of 6,627 HCA Healthcare, Inc. $HCA
Sandro Wealth Management LLC recently acquired 6,627 shares of HCA Healthcare, Inc. (NYSE:HCA) valued at approximately $2.584 million, making it about 1.9% of their portfolio. HCA Healthcare reported strong quarterly earnings with an EPS of $7.59 and revenue of $20.23 billion, exceeding analyst expectations, and declared a quarterly dividend of $0.78 per share. The company currently holds a "Moderate Buy" consensus rating from analysts with an average target price of $465.59.
What Does Lantheus Holdings (LNTH) FDA Approval Mean For Its Alzheimer’s Push?
Lantheus Holdings received FDA approval for TAUKLARIFY, a tau PET imaging agent for Alzheimer's disease diagnostics, expanding its molecular imaging portfolio beyond prostate cancer. This approval strengthens Lantheus's position in the Alzheimer's imaging market and supports its strategy of diversifying revenue and meeting the growing demand for early diagnosis of the disease. However, the company still faces execution risks and competition from other players in the PET imaging space.
Agilent Technologies, Inc. $A Stock Position Decreased by Assenagon Asset Management S.A.
Assenagon Asset Management S.A. significantly reduced its stake in Agilent Technologies (NYSE:A) by 75.3% in the second quarter, selling 31,934 shares. Despite this, other institutional investors like State Street Corp, Geode Capital Management LLC, and Morgan Stanley increased their holdings. Agilent Technologies reported strong quarterly earnings, beating analyst estimates, and maintains a "Moderate Buy" consensus rating from analysts with an average price target of $160.24.
News by ACCESS Newswire on TradingView, 2026-08-14
AI/ML Innovations Inc. (AIML) announced a proposed non-brokered private placement to raise up to $2,000,000. The company plans to issue up to 40,000,000 units at $0.05 per unit, with each unit comprising one common share and one common share purchase warrant. This offering is subject to regulatory approvals, including from the Canadian Securities Exchange.
GE HealthCare Technologies Inc. stock rises Thursday, outperforms market
GE HealthCare Technologies Inc. (GEHC) stock rose 2.09% on Thursday, closing at $73.79. This performance outpaced the broader market, with the S&P 500 Index gaining 0.65% and the Dow Jones Industrial Average rising 0.13%. The increase broke a two-day losing streak for the company's stock.
Mdxhealth Reports Second Quarter 2026 Financial Results
Mdxhealth reported a 16% increase in second-quarter 2026 revenue, reaching $27.2 million, driven by strong recovery in its tissue-based business and integration of ExoDx. The company reaffirmed its 2026 revenue guidance of $110-115 million and expects to return to positive adjusted EBITDA by the end of 2026. This growth follows the strategic discontinuation of its Resolve UTI offering and a recent registered direct placement of shares, strengthening its financial position.
Can BWX Technologies' Nuclear Medicine Expansion Boost Growth?
BWX Technologies (BWXT) is expanding its commercial nuclear portfolio into nuclear medicine and medical radioisotopes, driven by its acquisition of Kinectrics. This move allows BWXT to diversify its operations beyond traditional nuclear energy, leveraging increased demand for specialized medical applications. The company's earnings are projected to grow, and its stock is currently trading at a discount relative to its industry.
GE HealthCare Technologies (NASDAQ:GEHC) Stock Rating Upgraded by Zacks Research
Zacks Research upgraded GE HealthCare Technologies (NASDAQ:GEHC) stock from "strong sell" to "hold." This upgrade aligns with a broader analyst consensus of "hold" and a target price of $77.73, following the company's strong quarterly earnings report where it surpassed EPS expectations and saw a 5.8% year-over-year revenue increase. The article also notes recent insider buying and significant institutional ownership in the company.
GE HealthCare (GEHC) Upgraded to Buy: Here's What You Should Know
GE HealthCare (GEHC) has been upgraded to a Zacks Rank #2 (Buy) due to an upward trend in earnings estimates. The Zacks rating system highlights the strong correlation between earnings estimate revisions and near-term stock price movements, making this upgrade a positive indicator for GEHC's stock. The company's future earnings potential, reflected in rising estimates, suggests an improvement in its underlying business that could lead to higher stock prices.
General Electric Insider Sold Shares Worth $3,788,752, According to a Recent SEC Filing
An insider at General Electric (NYSE: GE) sold shares valued at $3,788,752, according to a recent SEC filing. The article, published by MT Newswires on MarketScreener, did not provide further details as it is reserved for members. General Electric, specifically GE Aerospace, focuses on manufacturing jet engines and aircraft systems, with significant operations across the United States, Asia, and Europe.
